- Home
- CRL vs CFR Comparison
CRL vs CFR Comparison
Compare CRL & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRL
- CFR
- Stock Information
- Founded
- CRL 1947
- CFR 1868
- Country
- CRL United States
- CFR United States
- Employees
- CRL N/A
- CFR N/A
- Industry
- CRL Biotechnology: Commercial Physical & Biological Resarch
- CFR Major Banks
- Sector
- CRL Health Care
- CFR Finance
- Exchange
- CRL Nasdaq
- CFR Nasdaq
- Market Cap
- CRL 9.8B
- CFR 8.9B
- IPO Year
- CRL 2000
- CFR N/A
- Fundamental
- Price
- CRL $186.29
- CFR $135.96
- Analyst Decision
- CRL Hold
- CFR Hold
- Analyst Count
- CRL 13
- CFR 13
- Target Price
- CRL $211.64
- CFR $125.38
- AVG Volume (30 Days)
- CRL 531.0K
- CFR 324.7K
- Earning Date
- CRL 02-12-2025
- CFR 01-23-2025
- Dividend Yield
- CRL N/A
- CFR 2.82%
- EPS Growth
- CRL N/A
- CFR N/A
- EPS
- CRL 8.00
- CFR 8.07
- Revenue
- CRL $4,060,916,000.00
- CFR $1,964,467,000.00
- Revenue This Year
- CRL N/A
- CFR N/A
- Revenue Next Year
- CRL $1.18
- CFR $2.52
- P/E Ratio
- CRL $23.28
- CFR $16.69
- Revenue Growth
- CRL N/A
- CFR 0.42
- 52 Week Low
- CRL $176.48
- CFR $94.09
- 52 Week High
- CRL $275.00
- CFR $147.64
- Technical
- Relative Strength Index (RSI)
- CRL 42.96
- CFR 50.14
- Support Level
- CRL $180.21
- CFR $130.36
- Resistance Level
- CRL $188.04
- CFR $134.87
- Average True Range (ATR)
- CRL 6.14
- CFR 3.29
- MACD
- CRL -1.04
- CFR -0.85
- Stochastic Oscillator
- CRL 27.01
- CFR 48.71
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional us bank with around $50 billion in assets (as of 2023 year-end), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.